Organism ID:   | NPO41848 |
Organism Name:   | A new engineered strain of Escherichia coli [lgtA wbgO] |
Native / Engineered Organism:   | Engineered Organism |
Matched Taxonomy Level:   | Strain |
Organism External ID:   | NCBI_Taxonomy_ID[ n.a.] |
Organism Synonyms:   | |
Genus:   | Escherichia |
Family:   | Enterobacteriaceae |
Kingdom:   | n.a. |
SuperKingdom:   | Bacteria |
Natural Product ID | Prefer Name (or InChiKey) | IUPAC Name | Number of Targets | Number of Activity Records |
---|---|---|---|---|
NPC161593 | Levodopa | (2S)-2-azaniumyl-3-(3,4-dihydroxyphenyl)propanoate | 94 | 564 |
Organism Name | Producer Organism | Inducer Organism | NP ID | NP Name | Effect of Co-culture | Reference |
---|
Organism Name | Parent Organism Name | Engineered Gene in Organism | Purpose of Engineering | Engineering Category | Engineering Description | NP ID | NP Name | NP Yeild of Parent Organism | NP Yeild of Engineered Organism | Yeild Change | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|
A new engineered strain of Escherichia coli | Escherichia coli | lgtA wbgO | Increase NP yield | n.a. | The strain was constructed by chromosomally integrating the genes lgtA and wbgO, encoding β-1,3-N-acetylglucosaminyltransferase and β-1,3-galactosyltransferase. | NPC161593 | L-DOPA | n.a. | 219.1±3.5 mg/L | n.a. |
PMID[25044565] |
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|